Pharmacy
Hospital are now left to question how they will be made whole and what HHS will set for future drug reimbursement.
Many heart failure patients are hesitant to get the COVID-19 vaccine due to fear of myocarditis, or inflammation of the heart muscle.
The groups said PBMs engage in anticompetitive practices that increase drug prices and limit consumer choice.
The agency is investigating the vertically integrated industry for its impact on the access and affordability of drugs.
New CMS report requested by HHS Secretary Becerra shows savings can be passed on to Medicare beneficiaries in 2023.
PhRMA claims insurers could use the rule to siphon the cost-sharing assistance from counting toward deductibles and out-of-pocket maximums.
The decision was based on an analysis of immune response data, as well as the impacts of the Omicron variant.
Controlling COVID-19 globally requires the most vulnerable to have access to lifesaving treatments, says HHS Secretary Xavier Becerra.
The proposed transaction includes Pfizer's acquisition of Biohaven's migraine drugs, including rimegepant and zavegepant.
Rising case counts among children complicate efforts to reduce the burden on the American healthcare system.